AzTrials
AzTrials

Psychological OutcomesNCT07814911

Acceptance and Commitment Therapy for Parenting Children With Cerebral Palsy

A study testing ACT intervention in people with Psychological Outcomes and Quality of Life, run by The Hong Kong Polytechnic University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this randomized controlled trial is to evaluate whether a group-based acceptance and commitment therapy (ACT) can improve the psychological outcomes and quality of life (QOL) of children with cerebral palsy. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Psychological Outcomes, Quality of Life
What is being tested?
ACT intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
No sites listed yet
Study dates
1 Oct 2026to 31 Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Parents of children under 18 years with any type and severity of cerebral palsy
  • Able to communicate in Amharic, and
  • Able to provide written consent for participation

Who cannot join

  • Participants who have known psychological or psychiatric problems, and
  • Participants who are currently participating or have participated in another similar or related study within six months

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Kenneth N.K Fong, PhD contact

+852 2766 6716

rsnkfong@polyu.edu.hk

Tenaw Gualu Melesse, PhD contact

+852 5530 4750

tgmeles@polyu.edu.hk

About this study

Official title: Effects of Acceptance and Commitment Therapy on Psychological Outcomes and Quality of Life of Parents of Children With Cerebral Palsy: A Randomized Controlled Trial.

The goal of this randomized controlled trial is to evaluate whether a group-based acceptance and commitment therapy (ACT) can improve the psychological outcomes and quality of life (QOL) of children with cerebral palsy. The main questions it aims to answer are:

  • Does a group-based ACT improve the psychological flexibility of the participants?
  • Does a group-based ACT improve the psychological distress, including depression, anxiety, and stress, of the participants?
  • Does a group-based ACT improve the QOL of the participants?
Read more

Researchers will compare a group-based ACT to usual/standard care to determine whether ACT improves participants' psychological outcomes and QOL.

Participants will:

  • Receive eight weekly, face-to-face, group-based ACT sessions, each lasting approximately 90 minutes.
  • Receive home-based practices following each session.
  • Receive a weekly phone call assessment to address any study-related concerns and provide reminders for the next appointment or assessment day.
  • Complete the questionnaires at three times: baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).
Being tested
ACT intervention, Usual/standard control
Keywords
Acceptance and Commitment Therapy, Psychological outcome, Anxiety, Depression, Stress, Psychological flexibility, Quality of life, Child, Parent, Cerebral palsy
Medical subject headings
Anxiety Disorders, Depression, Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ACT interventionBehavioural

    Participants in the intervention group will receive an ACT that consists of eight sessions. Th introductions include an introduction, cognitive defusion, acceptance, being present, values, committed action, and noticing self/self-as context, and a summary session. An ACT-trained researcher will deliver weekly, face-to-face, group-based sessions, each lasting approximately 90 minutes, though durations may vary to accommodate group variations. Each group will consist of five to seven participants.

    The interventions will be delivered via various strategies, including psychoeducation, discussion, mindfulness exercises, and metaphors supplemented with with home practices.

    A research assistant will conduct a weekly phone call assessment to address any study-related concerns and provide reminders for the next appointment or assessment day.

  • Usual/standard controlOther

    Participants in the control group will receive the usual or standard care provided by the respective center. To enhance participant retention in the study, a weekly phone call will be conducted by a research assistant, during which participants will be asked whether they have any concerns about the study and reminded of the next appointment or assessment day.

Study groups in NCT07814911
Study groupRoleWhat they receive
ACT interventionExperimentalNot described
Receives: Behavioral: ACT intervention
Usual/standard treatmentOtherNot described
Receives: Other: Usual/standard control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Level of psychological flexibility

    The psychological flexibility will be assessed using the 7-item Acceptance and Action Questionnaire-II (AAQ-II). Each item in the AAQ-II is scored on a scale of seven from 1(never true) to 7(always true). The total score is obtained by summing the scores of all items, and the higher the total score indicates greater psychological inflexibility.

    Measured: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).

  2. Level of psychological distress

    The psychological distress outcomes including, anxiety, depression, and stress will be assessed using the self-report 21-item anxiety, depression, and stress scale (DASS-21).

    Each of the subscales comprises 7 items and is scored on a four-point Likert scale ranging from 0(didn't apply at all to me) to 3(applied to me very much or most of the time), and the score is calculated by summing up the items in each subscale, and the final core is obtained by multiplying the core by two to make it comparable with the full scale (DASS-42). The higher the core indicates high distress symptoms.

    Measured: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).

Secondary outcomes (1)
  1. Level of quality of life

    The quality of life will be evaluated by using the World Health Organization Quality of Life-BREF (WHOQOL-BREF).

    It comprises four domains: physical health, psychological, social relationships, and environment. Each item is scored on a five-point scale from 1 to 5, with varying response options across the domains, and some items need to be reversely scored. There are two items examined separately and will not be included in the score calculation. Domain scores are calculated by summing up the mean of all items in each domain and multiplying by four, and then the total score is transformed to a 0-100 scale to make the domains comparable. A higher the score indicates a higher QOL.

    Measured: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion31 Jan 2027 (estimated)
  4. Study completion31 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
76 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07814911
Sponsor's protocol ID
HSEARS20260707001
Status last verified
Sep 2026
First submitted
6 Sep 2026
Last updated
11 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing ACT intervention in people with Psychological Outcomes and Quality of Life, run by The Hong Kong Polytechnic University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Kenneth N.K Fong, PhD (+852 2766 6716, rsnkfong@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Level of psychological flexibility (time frame: Baseline (before intervention), post-intervention (at 8 weeks), and follow-up (6 weeks post-intervention).). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in